Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834924 · ClinicalTrials.gov registry record · NA
Improving Communication of Medication Instructions to Parents
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,196
- Enrollment target
NCT01834924: Completed NA study, sponsored by NYU Langone Health.
NCT01834924 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834924, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,196 participants
- Enrollment target
Study Summary
Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administering medications to their children; difficulty understanding provider medication instructions is likely to contribute to errors. To address these issues, bilingual (English/Spanish), low literacy, picture-based medication instruction sheets were developed. This study will look at the effectiveness and feasibility of the medication instruction sheet-based intervention as it is used by providers in 2 pediatric emergency department settings, as part of a planned roll out of HELPix within the hospital system. The investigators hypothesize that there will be reduced medication dosing errors, improved medication adherence, reduced hospital revisit rates, and improved provider-parent communication. The investigators also hypothesize that provider technology experience, knowledge, and attitudes, will affect the extent to which providers use the tool.
Primary Outcome
Dosing error defined as \>20% deviation from prescribed dose
Interventions
- OTHER HELPix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,196 participants |
| Start Date | 2010-05-31 |
| Est. Completion | 2015-01-09 |
| Phase | NA |
What the finished NCT01834924 record still lists
NCT01834924 is an interventional study that assigns participants to a tested intervention. Its 1,196 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 1 intervention - of which HELPix is the first listed.
NCT01834924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01834924 about?
NCT01834924 is a clinical study titled "Improving Communication of Medication Instructions to Parents". Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administer...
What is the current status of trial NCT01834924?
This trial is currently completed. It is a NA study. The enrollment target is 1,196 participants. The study started on 2010-05-31. Estimated completion is 2015-01-09.
What interventions are being tested in trial NCT01834924?
The interventions under investigation include: HELPix (OTHER).
Who is sponsoring clinical trial NCT01834924?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01834924's enrollment target sits among peer trials
1,196 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI